Real-world assessment of clinical effectiveness and safety of pazopanib in patients with advanced or metastatic renal cell carcinoma (RCC) in Asia, North Africa and Middle East countries: A prospective, observational study (PARACHUTE)
European-Society-for-Medical-Oncology (ESMO) Asia Congress, Singapore, Singapore, 22 - 24 November 2019, vol.30, (Summary Text)
- Publication Type: Conference Paper / Summary Text
- Volume: 30
- City: Singapore
- Country: Singapore
- Hacettepe University Affiliated: Yes